Pureca Laboratories Private Limited
About Pureca Laboratories Private Limited
Data last updated:
Pureca Laboratories Private Limited is a private limited company based in Delhi, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 22 May 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2012PTC236285. Its GSTIN is 07AAGCP6172K1Z1 (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Vaibhav Vohra and Arpit Vohra.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Built Up Industrial Plot No. – 1 Pocket – B Sector – 4 Dsiidc Complex Bawa, Delhi, India – 110039.
As per the financials filed for FY 2022, the company reported a revenue of ₹10.57 Cr, a decline of 57% compared to the previous year. For the same year it recorded a net profit of ₹4.82 Lakh (net margin 0.5%) and EBITDA of ₹30.89 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 5% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
Court records list 68 cases involving the company, including 6 filed by the company and 62 filed against it; 44 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Pureca Laboratories Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBuilt Up Industrial Plot No. – 1 Pocket – B Sector – 4 Dsiidc Complex Bawa, Delhi, India – 110039
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Pureca Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pureca Laboratories is hospital and medical care. In detail, this covers hospital activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities |
To see the full business activity and turnover split of Pureca Laboratories Private Limited, buy the company report.
Financials of Pureca Laboratories Private Limited
FY 2022 filings availablePureca Laboratories Private Limited reported revenue of ₹10.57 Cr (down 57% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue fell 57% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30.89 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.82 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pureca Laboratories Private Limited, buy the company report.
Board of directors of Pureca Laboratories Private Limited
Pureca Laboratories has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vaibhav Vohra Also directs: Oplos Medicare Pharmaceuticals Private Limited | Director | 22 May 2012 | 14 Years 5 Months | Current |
| Arpit Vohra | Director | 22 May 2012 | 14 Years 5 Months | Current |
Auditor
Pureca Laboratories Private Limited is audited by MODI DHAVALAGI & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MODI DHAVALAGI & CO | FY 2018 | 009187S |
Shareholding
The shareholding of Pureca Laboratories Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Pureca Laboratories Private Limited, buy the company report.
Legal cases
Pureca Laboratories Private Limited has 68 court cases on record: 6 filed by Pureca Laboratories, 62 filed against it. 44 cases are pending and 24 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 54 | 54 | 38 |
| High courts | 14 | 8 | 6 |
Cases on record (5 of 68)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (SW CASES W) | Filed against the company by Dipali Enterprises Pvt Ltd Through Director Dipak Kantilal Shah | Pending |
| District court, Central, Delhi | Cheque dishonour complaint | Filed against the company by M/S SMX Farma Ltd | Pending |
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed against the company by Reddy Pharmaceuticals Ltd., Rep by Raghurami Reddy | Pending |
| District court, Indore, Madhya Pradesh | Court case (UN CR) | Filed against the company by Erawat Pharma Ltd Thro. Pradeep and 1 other | Pending |
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed by the company against Apex Laboratories Private Limited | Disposed |
To see the full case history of Pureca Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pureca Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Pureca Laboratories Private Limited has a workforce of 4 employees on its EPFO records as of Mar 24, 2024, across 1 active EPFO establishment.
GST
Pureca Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCP6172K1Z1 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pureca Laboratories Private Limited, buy the company report.
Recent activity
Pureca Laboratories Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Subhash Chandra Vohra ceased to be Director on 15 May 2021.
Frequently asked questions
Pureca Laboratories is an active private limited company based in Delhi, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 22 May 2012 (14+ years old) and is registered under CIN U24100DL2012PTC236285.
Pureca Laboratories has 2 current directors:
- Vaibhav Vohra - Director
- Arpit Vohra - Director
The latest financial statements of Pureca Laboratories on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Pureca Laboratories is 07AAGCP6172K1Z1, registered in Delhi.
The CIN (Corporate Identification Number) of Pureca Laboratories is U24100DL2012PTC236285. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pureca Laboratories has 68 court cases on record: 6 filed by the company and 62 filed against it. 44 are pending. Most are in the district courts.
Pureca Laboratories was incorporated on 22 May 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Subhash Chandra Vohra ceased to be Director on 15 May 2021. Arpit Vohra was appointed as Director on 22 May 2012. Vaibhav Vohra was appointed as Director on 22 May 2012.
The registered office of Pureca Laboratories is at Built Up Industrial Plot No. – 1 Pocket – B Sector – 4 Dsiidc Complex Bawa, Delhi, India – 110039.
Pureca Laboratories operates in the chemicals and materials industry, in the industrial chemicals segment.